Your browser doesn't support javascript.
loading
Endocytic pathway inhibition attenuates extracellular vesicle-induced reduction of chemosensitivity to bortezomib in multiple myeloma cells.
Tu, Chenggong; Du, Zhimin; Zhang, Hui; Feng, Yueyuan; Qi, Yujun; Zheng, Yongjiang; Liu, Jinbao; Wang, Jinheng.
Afiliação
  • Tu C; Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou 510095, China.
  • Du Z; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation; State Key Laboratory of Respiratory Disease; School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou 511436, China.
  • Zhang H; School of Nursing, Guangzhou Medical University, Guangzhou 510182, China.
  • Feng Y; Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou 510095, China.
  • Qi Y; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation; State Key Laboratory of Respiratory Disease; School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou 511436, China.
  • Zheng Y; Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou 510095, China.
  • Liu J; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation; State Key Laboratory of Respiratory Disease; School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou 511436, China.
  • Wang J; Zhengzhou University School of Medicine, Zhengzhou 450052, China.
Theranostics ; 11(5): 2364-2380, 2021.
Article em En | MEDLINE | ID: mdl-33500730

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Endocitose / Vesículas Extracelulares / Bortezomib / Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Endocitose / Vesículas Extracelulares / Bortezomib / Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article